Work

Supplementary Fig. S5 from PERK Inhibition by HC-5404 Sensitizes Renal Cell Carcinoma Tumor Models to Antiangiogenic Tyrosine Kinase Inhibitors

Year: 2023

Type: supplementary-materials

Abstract: Pericyte markers are suppressed by VEGFR-TKI and HC-5404 combination treatments.

DOI: 10.1158/1078-0432.24710752.v1

Authors: Michael E. Stokes, Veronica Calvo, Sho Fujisawa, Crissy Dudgeon, Sharon Huang, Nupur Ballal, Leyi Shen, Jennifer Gasparek, Matthew Betzenhauser, Simon J. Taylor, Kirk A. Staschke, Alan C. Rigby, Mark J. Mulvihill, Nandita Bose, Eric S. Lightcap, David Surguladze

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4389242574

Cites:

Cited by:

Related to: 10